Prelude Capital Management, LLC Accelerate Diagnostics, Inc Call Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$14.6 - $18.13 $547,500 - $679,875
-37,500 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$16.62 - $23.92 $41,550 - $59,800
-2,500 Reduced 6.25%
37,500 $696,000
Q2 2019

Aug 14, 2019
BUY
$17.79 - $22.88 $709,821 - $912,912
39,900 Added 39900.0%
40,000 $915,000
Q4 2018

Feb 14, 2019
BUY
$10.42 - $21.94 $1,042 - $2,194
100 New
100 $1,000

Others Institutions Holding AXDX

# of Institutions
3
Shares Held
549K
Call Options Held
0
Put Options Held
0
View Full List

About Accelerate Diagnostics, Inc

AXDX Quotes by TradingView
  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $146M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email